Lexicon Pharma (LXRX) Tops Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.18 +6.86%
Revenue Growth %: -78.9%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -78.9%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.04), $0.24 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $110 thousand.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Meta bull case increasingly playing out, Mizuho says
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
